Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent RE49850 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 2 Mar, 2024
"Created via: Patent importer"
Golden AI
created this topic on 2 Mar, 2024
Edits made to:
Infobox
(
+16
properties)
US Patent RE49850 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
RE49850
0
Patent Inventor Names
Mingfeng Yu
0
Shudong Wang
0
Solomon Tadesse Zeleke
0
Date of Patent
February 27, 2024
0
Patent Application Number
17591158
0
Date Filed
February 2, 2022
0
Patent Citations
US Patent 7432260 Pyrimidine compounds
0
US Patent 7897605 Pyrimidine compounds
0
US Patent 7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
0
Patent Primary Examiner
Alan D Diamond
0
CPC Code
C07D 417/14
0
A61P 35/00
0
A61P 35/02
0
Find more entities like US Patent RE49850 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE